BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16307437)

  • 1. Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A.
    Massa R; Palumbo C; Cavallaro T; Panico MB; Bei R; Terracciano C; Rizzuto N; Bernardi G; Modesti A
    Muscle Nerve; 2006 Mar; 33(3):342-9. PubMed ID: 16307437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination.
    Sahenk Z
    Ann N Y Acad Sci; 1999 Sep; 883():415-26. PubMed ID: 10586265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish.
    Lyons DA; Pogoda HM; Voas MG; Woods IG; Diamond B; Nix R; Arana N; Jacobs J; Talbot WS
    Curr Biol; 2005 Mar; 15(6):513-24. PubMed ID: 15797019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral nerve extracellular matrix remodeling in Charcot-Marie-Tooth type I disease.
    Palumbo C; Massa R; Panico MB; Di Muzio A; Sinibaldi P; Bernardi G; Modesti A
    Acta Neuropathol; 2002 Sep; 104(3):287-96. PubMed ID: 12172915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease.
    Fornasari BE; Ronchi G; Pascal D; Visigalli D; Capodivento G; Nobbio L; Perroteau I; Schenone A; Geuna S; Gambarotta G
    Exp Biol Med (Maywood); 2018 Feb; 243(4):370-374. PubMed ID: 29350067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration.
    Carroll SL; Miller ML; Frohnert PW; Kim SS; Corbett JA
    J Neurosci; 1997 Mar; 17(5):1642-59. PubMed ID: 9030624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of neuregulin isoforms and erbB receptors in myelinating glial cells.
    Raabe TD; Deadwyler G; Varga JW; Devries GH
    Glia; 2004 Jan; 45(2):197-207. PubMed ID: 14730713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.
    Stonecypher MS; Byer SJ; Grizzle WE; Carroll SL
    Oncogene; 2005 Aug; 24(36):5589-605. PubMed ID: 15897877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells into Schwann-Like Cells Improves Neuromuscular Function in a Mouse Model of Charcot-Marie-Tooth Disease Type 1A.
    Park S; Jung N; Myung S; Choi Y; Chung KW; Choi BO; Jung SC
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A.
    Atanasoski S; Scherer SS; Nave KA; Suter U
    J Neurosci Res; 2002 Feb; 67(4):443-9. PubMed ID: 11835311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in Charcot-Marie-Tooth disease type 1A.
    Koike H; Iijima M; Mori K; Yamamoto M; Hattori N; Katsuno M; Tanaka F; Watanabe H; Doyu M; Yoshikawa H; Sobue G
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1027-36. PubMed ID: 17984684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
    Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
    Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of the Charcot-Marie-Tooth associated MTMR2 gene decreases proliferation and enhances cell death in primary cultures of Schwann cells.
    Chojnowski A; Ravisé N; Bachelin C; Depienne C; Ruberg M; Brugg B; Laporte J; Baron-Van Evercooren A; LeGuern E
    Neurobiol Dis; 2007 May; 26(2):323-31. PubMed ID: 17336078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oct6, a transcription factor controlling myelination, is a marker for active nerve regeneration in peripheral neuropathies.
    Kawasaki T; Oka N; Tachibana H; Akiguchi I; Shibasaki H
    Acta Neuropathol; 2003 Mar; 105(3):203-8. PubMed ID: 12557005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.
    Fledrich R; Akkermann D; Schütza V; Abdelaal TA; Hermes D; Schäffner E; Soto-Bernardini MC; Götze T; Klink A; Kusch K; Krueger M; Kungl T; Frydrychowicz C; Möbius W; Brück W; Mueller WC; Bechmann I; Sereda MW; Schwab MH; Nave KA; Stassart RM
    Nat Commun; 2019 Apr; 10(1):1467. PubMed ID: 30931926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy.
    Ravera S; Nobbio L; Visigalli D; Bartolucci M; Calzia D; Fiorese F; Mancardi G; Schenone A; Morelli A; Panfoli I
    J Neurochem; 2013 Jul; 126(1):82-92. PubMed ID: 23578247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy.
    Nobbio L; Fiorese F; Vigo T; Cilli M; Gherardi G; Grandis M; Melcangi RC; Mancardi G; Abbruzzese M; Schenone A
    J Neuropathol Exp Neurol; 2009 May; 68(5):441-55. PubMed ID: 19525893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.